Who We Are
Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Our programs have the potential to dramatically improve patient care in major markets.
Our focused, science-based approach rests on three pillars, uniquely positioning us for growth in this dynamic biopharmaceutical sector:
We believe the science will lead us to the most promising therapeutic applications, and that our drug development discipline will provide patients access to superior products and result in better outcomes.
We are driving forward a diversified portfolio of product candidates unified by their to ability to modulate the endocannabinoid system, yet unique in their mechanism of action, stage of development, and targeted therapeutic applications.
We are applying a leading level of biopharma discipline, supported by our management’s track record of entrepreneurial and commercial success, our scientific team’s deep understanding of the endocannabinoid system, and our board’s successful performance over several decades.
Vision and culture
We expect to deliver on the promise of new medicines to treat a wide range of diseases and conditions for patients in need of better outcomes. By doing so, we will create value for patients, physicians, and our investors.
To realize our objectives, we will:
- Focus on providing patient access to new therapies
- Drive innovative endocannabinoid system modulating therapeutics into new frontiers
- Apply proven biopharma rigor to our development initiatives
- Vigorously protect intellectual property and portfolio value
- Partner with world-class experts who share our drive and passion for success
Our five guiding principles empower our corporate culture:
- Prioritize Innovation
- Act with Trust & Integrity
- Be Decisive
- Encourage Speed and Simplicity
- Foster Teamwork